Acetiromate

Acetiromate_skeletal.svg

Acetiromate is a pharmaceutical drug used primarily in the treatment of hypercholesterolemia and other related cardiovascular diseases. It belongs to the class of drugs known as statins, which function by inhibiting the enzyme HMG-CoA reductase, a key enzyme in the mevalonate pathway responsible for cholesterol synthesis in the liver.

Mechanism of Action

Acetiromate works by competitively inhibiting HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, a precursor of cholesterol. By reducing the synthesis of cholesterol, Acetiromate lowers the levels of low-density lipoprotein (LDL) cholesterol in the blood, which is often referred to as "bad cholesterol." This reduction in LDL cholesterol helps to decrease the risk of atherosclerosis and subsequent cardiovascular events such as heart attacks and strokes.

Indications

Acetiromate is indicated for:

• The treatment of hypercholesterolemia
• The prevention of cardiovascular disease in patients with multiple risk factors
• The reduction of LDL cholesterol levels in patients with familial hypercholesterolemia

Side Effects

Common side effects of Acetiromate include:

• Myalgia (muscle pain)
• Nausea
• Headache
• Elevated liver enzymes

Serious but rare side effects may include:

• Rhabdomyolysis
• Severe allergic reactions
• Liver damage

Contraindications

Acetiromate is contraindicated in patients with:

• Liver disease
• Pregnancy
• Known hypersensitivity to the drug or its components

Drug Interactions

Acetiromate may interact with other medications, including:

• Other statins
• Fibrates
• Warfarin
• Certain antibiotics and antifungals

Dosage and Administration

The dosage of Acetiromate varies depending on the patient's condition and response to treatment. It is typically administered orally, once daily, with or without food. Regular monitoring of liver function tests and lipid levels is recommended during treatment.

History

Acetiromate was developed in the early 21st century as part of ongoing research into more effective treatments for hypercholesterolemia and cardiovascular disease. It was approved by regulatory agencies after extensive clinical trials demonstrated its efficacy and safety.

See Also

• Statins
• Hypercholesterolemia
• Cardiovascular disease
• HMG-CoA reductase

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian